Trial intelligence / Profile preview

Bemiparin versus enoxaparin for prevention of deep vein thrombosis after plastic and reconstructive surgery

ISRCTN13851176Phase 2Completed

Sponsor
Centro Médico ABC
Start
May 2016
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 2, single-blind trial of bemiparin and enoxaparin in deep vein thrombosis (DVT) (2 arms), sponsored by Centro Médico ABC. Primary endpoint: Lower limb thrombogenesis. Started May 2016; status: completed.

02

Drugs

bemiparinenoxaparin
03

Conditions

deep vein thrombosis (DVT)

Beyond the preview

Go deeper on ISRCTN13851176.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN13851176.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call